Skip to content

Deep Inferior Epigastric Artery Flap for Breast Reconstruction

Division of Plastic and Reconstruction Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05088239
Enrollment
108
Registered
2021-10-21
Start date
2011-07-01
Completion date
2020-12-31
Last updated
2021-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-Infectives Adverse Reaction, Breast Cancer, Infections, Perforator Flap

Keywords

Prophylatic antibiotics, DIEP flap

Brief summary

Background: There is no consensus on the duration of prophylactic antibiotics for autologous breast reconstruction after mastectomy. We try to standardize prophylactic antibiotics use during breast reconstruction with deep inferior epigastric perforator flap following mastectomy. Methods: This retrospective case series involved 108 patients who underwent immediate breast reconstruction with deep inferior epigastric perforator flap in Ditmanson Medical Foundation Chia-Yi Christian Hospital between 2012 and 2019. Patients were divided into three groups based on prophylactic antibiotic duration: 1 day, 3 days and \>7 days for patients with drains Data were analyzed between January and April, 2021.

Interventions

DRUGprophylactic antibiotics duration

Prophylactic cefazolin 1000 mg was given 30 minutes before surgery, every 4 hours in the peri-operative period, and every 6 hours in the post-operative care. Different discontinued duration of antibiotics was divided to 3 groups in one day, 3 days and until to drain removal.

Sponsors

Chiayi Christian Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
24 Years to 63 Years
Healthy volunteers
No

Inclusion criteria

* This retrospective study involved 108 patients who underwent immediate DIEP flap breast reconstruction after unilateral or bilateral mastectomy at the Ditmanson Medical Foundation Chia-Yi Christian Hospital between 2012 and 2019.

Exclusion criteria

* Age \< 20 years old.

Design outcomes

Primary

MeasureTime frameDescription
surgical site infection (SSI)Patients were then followed up in the outpatient department for 1 year.Infection rate of surgical wounds of breast and abdomen.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026